Search

Peter Mac has received a significant Medical Research Future Fund (MRFF) grant close to $3 million to harness the next generation of liquid biopsy assays for clinical translation in breast cancer. The funding is one of two MRFF... Read more

Chronic lymphocytic leukaemia (CLL) patients who are refractory or resistant to treatment can be encouraged by data showing significantly longer survival without disease progression with a treatment combining venetoclax and... Read more

DNA and RNA are molecules made up of a four-letter genetic code (nucleotides), a principle that is conserved across all living organisms. The human genome, encompassing the entire genetic code, comprises approximately three... Read more

Sitting at home in Swan Hill in Victoria’s north, patient Darrell Hampton, 69, has nothing but a “red dot” on his head where a melanoma tumour used to be.  He was the first Australian patient to be treated for... Read more

Peter Mac experts visited Methodist Ladies College last week, speaking to students about their work, Peter Mac, and the future of STEM. Nine Peter Mac speakers discussed their work and careers, four delivering keynote... Read more

Our world leading research featured in the recent newsProsTIC Director awarded Saul Hertz Award  The 2024 Saul Hertz, MD Award is presented to Professor Michael Hofman by the Society of Nuclear Medicine and Molecular... Read more